Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures.
At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside.
Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve.
For more information, please visit www.ovidrx.com.
Review our community guidelines: http://www.ovidrx.com/community-guidelines/
Company Details
- Employees
- 39
- Founded
- -
- Address
- 441 9th Avenue, New York,new York 10001,united States
- Phone
- (212) 776-4381
- in****@****drx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ovidrx.com
- Keywords
- jobs.
- HQ
- New York, New York
Ovid Therapeutics Questions
Ovid Therapeutics's helpline number is (212) 776-4381
Ovid Therapeutics's website is ovidrx.com
Ovid Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ovid-therapeutics
Ovid Therapeutics has
39 employees.
View email and phone details for 39
employees at Ovid Therapeutics.
Ovid Therapeutics's industry is
Biotechnology Research
Ovid Therapeutics's top competitors are
Tg Therapeutics, Inc.,
Prevail Therapeutics,
Tevard Biosciences,
Adc Therapeutics,
Ars Pharmaceuticals, Inc.,
Zealand Pharma,
Rocket Pharmaceuticals,
Lykos Therapeutics,
Actuate Therapeutics, Inc.,
Halda Therapeutics.
Ovid Therapeutics's support email address is info@ovidrx.com
Ovid Therapeutics's categories are Biotechnology Research
Ovid Therapeutics's founding year is 2014
